P013 A three-year audit of dose tapering biologic medications in a rheumatology service
Sign Up to like & getrecommendations! Published in 2023 at "Rheumatology"
DOI: 10.1093/rheumatology/kead104.055
Abstract: Dose tapering of biologic therapies is supported by both ACR and EULAR guidelines. Identification of appropriate patients may deliver cost savings whilst minimising the risk of disease flare. To audit dose tapering activity for patients… read more here.
Keywords: rheumatology; year; dose tapering; tapering biologic ... See more keywords